There are 28 resources available
Welcome and Introduction
Presenter: S. Peters, CH and D. Planchard, FR
Session: Welcome and Introduction
Resources:
Slides
Adjuvant RT for Completely Resected Early Stage NSCLC and Treatment of Oligometastatic Disease NSCLC
Presenter: C. Le Pechoux, FR
Session: Session 1 – Multimodality Treatment in Early Stage
Resources:
Slides
IO or Targeted Therapies in the Peri-operative Setting for NSCLC
Presenter: J. Remon, FR
Session: Session 1 – Multimodality Treatment in Early Stage
Resources:
Slides
Stereotactic Ablative RT for Early Stage NSCLC
Presenter: C. Faivre-Finn, UK
Session: Session 1 – Multimodality Treatment in Early Stage
Resources:
Slides
Participants Clinical Case Discussion - Individualizing Neoadjuvant strategies in LA-NSCLC: The relevance of Molecular Diagnosis
Presenter: J. C. L. Montes, ES
Session: Session 1 – Multimodality Treatment in Early Stage
Resources:
Slides
Participants Clinical Case Discussion - Long-term Disease Control with Local Therapy for Oligoprogressive Disease During Immunotherapy in NSCLC
Presenter: A. Vilalta-Lacarra, ES
Session: Session 1 – Multimodality Treatment in Early Stage
Resources:
Slides
The Treatment Paradigm for Unresectable Stage III NSCLC
Presenter: F. Barlesi, FR
Session: Session 2 – Immuno-oncology treatment paradigms
Resources:
Slides
Treatment of Metastatic NSCLC with PD-L1 Expression and Without Oncogene Addiction
Presenter: A. Passaro, IT
Session: Session 2 – Immuno-oncology treatment paradigms
Resources:
Slides
Treatment of Metastatic NSCLC with Absent PD-L1 Expression and Without Oncogene Addiction
Presenter: S. Peters, CH
Session: Session 2 – Immuno-oncology treatment paradigms
Resources:
Slides
Participants Clinical Case Discussion - Mono-IO or not: That is the Question
Presenter: L. Mollica, IT
Session: Session 2 – Immuno-oncology treatment paradigms
Resources:
Slides